135 related articles for article (PubMed ID: 18624608)
1. Inverse relationship between adiponectin and plasminogen activator inhibitor-1 in metabolic syndrome patients.
Bilgili S; Celebiler AC; Dogan A; Karaca B
Endocr Regul; 2008 Jun; 42(2-3):63-8. PubMed ID: 18624608
[TBL] [Abstract][Full Text] [Related]
2. Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome.
Bahia L; Aguiar LG; Villela N; Bottino D; Godoy-Matos AF; Geloneze B; Tambascia M; Bouskela E
Clinics (Sao Paulo); 2006 Oct; 61(5):433-40. PubMed ID: 17072441
[TBL] [Abstract][Full Text] [Related]
3. Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome.
Valle M; Martos R; Gascón F; Cañete R; Zafra MA; Morales R
Diabetes Metab; 2005 Feb; 31(1):55-62. PubMed ID: 15803114
[TBL] [Abstract][Full Text] [Related]
4. Imbalance between protective (adiponectin) and prothrombotic (Plasminogen Activator Inhibitor-1) adipokines in metabolic syndrome.
Ahirwar AK; Jain A; Goswami B; Bhatnagar MK; Bhatacharjee J
Diabetes Metab Syndr; 2014; 8(3):152-5. PubMed ID: 25042166
[TBL] [Abstract][Full Text] [Related]
5. Glucometabolic hormones and cardiovascular risk markers in antipsychotic-treated patients.
Ebdrup BH; Knop FK; Madsen A; Mortensen HB; Søgaard B; Holst JJ; Szecsi PB; Lublin H
J Clin Psychiatry; 2014 Sep; 75(9):e899-905. PubMed ID: 25295432
[TBL] [Abstract][Full Text] [Related]
6. Inverse relationship between plasminogen activator inhibitor-I activity and adiponectin in overweight and obese women. Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol and inflammation.
Mertens I; Ballaux D; Funahashi T; Matsuzawa Y; Van der Planken M; Verrijken A; Ruige JB; Van Gaal LF
Thromb Haemost; 2005 Dec; 94(6):1190-5. PubMed ID: 16411393
[TBL] [Abstract][Full Text] [Related]
7. Association of low adiponectin levels with the metabolic syndrome--the Chennai Urban Rural Epidemiology Study (CURES-4).
Mohan V; Deepa R; Pradeepa R; Vimaleswaran KS; Mohan A; Velmurugan K; Radha V
Metabolism; 2005 Apr; 54(4):476-81. PubMed ID: 15798954
[TBL] [Abstract][Full Text] [Related]
8. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes.
Kahn SE; Zinman B; Haffner SM; O'Neill MC; Kravitz BG; Yu D; Freed MI; Herman WH; Holman RR; Jones NP; Lachin JM; Viberti GC;
Diabetes; 2006 Aug; 55(8):2357-64. PubMed ID: 16873701
[TBL] [Abstract][Full Text] [Related]
9. Independent positive association of plasma β-carotene concentrations with adiponectin among non-diabetic obese subjects.
Ben Amara N; Tourniaire F; Maraninchi M; Attia N; Amiot-Carlin MJ; Raccah D; Valéro R; Landrier JF; Darmon P
Eur J Nutr; 2015 Apr; 54(3):447-54. PubMed ID: 24906472
[TBL] [Abstract][Full Text] [Related]
10. Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study.
Lau CH; Muniandy S
Cardiovasc Diabetol; 2011 Jan; 10():8. PubMed ID: 21251282
[TBL] [Abstract][Full Text] [Related]
11. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
[TBL] [Abstract][Full Text] [Related]
12. Ramadan Intermittent Fasting Affects Adipokines and Leptin/Adiponectin Ratio in Type 2 Diabetes Mellitus and Their First-Degree Relatives.
Abdullah K; Al-Habori M; Al-Eryani E
Biomed Res Int; 2020; 2020():1281792. PubMed ID: 32775407
[TBL] [Abstract][Full Text] [Related]
13. Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects.
Al-Hamodi Z; Ismail IS; Saif-Ali R; Ahmed KA; Muniandy S
Cardiovasc Diabetol; 2011 Mar; 10():23. PubMed ID: 21414238
[TBL] [Abstract][Full Text] [Related]
14. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
Appel SJ; Harrell JS; Davenport ML
J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
[TBL] [Abstract][Full Text] [Related]
15. Adipocytokines in primary antiphospholipid syndrome: potential markers of low-grade inflammation, insulin resistance and metabolic syndrome.
Rodrigues CE; Vendramini MB; Bueno C; Bonfá E; de Carvalho JF
Clin Exp Rheumatol; 2012; 30(6):871-8. PubMed ID: 22935544
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin as a biomarker of clinical manifestation of metabolic syndrome.
Tajtákova M; Petrásova D; Petrovicová J; Pytliak M; Semanová Z
Endocr Regul; 2006 Mar; 40(1):15-9. PubMed ID: 16964963
[TBL] [Abstract][Full Text] [Related]
17. [Metformin hydrochloride ameliorates adiponectin levels and insulin sensitivity in adolescents with metabolic syndrome].
Liang L; Fu JF; Zou CC; Hong F; Wang CL; Wang XM
Zhonghua Er Ke Za Zhi; 2006 Feb; 44(2):118-21. PubMed ID: 16624028
[TBL] [Abstract][Full Text] [Related]
18. Association between hypoadiponectinemia and cardiovascular risk factors in nonobese healthy adults.
Im JA; Kim SH; Lee JW; Shim JY; Lee HR; Lee DC
Metabolism; 2006 Nov; 55(11):1546-50. PubMed ID: 17046559
[TBL] [Abstract][Full Text] [Related]
19. Use of confirmatory factor analysis for the identification of new components of the metabolic syndrome: the role of plasminogen activator inhibitor-1 and Haemoglobin A1c.
Boronat M; Saavedra P; Varillas VF; Nóvoa FJ
Nutr Metab Cardiovasc Dis; 2009 May; 19(4):271-6. PubMed ID: 18809301
[TBL] [Abstract][Full Text] [Related]
20. Relationship between plasma adiponectin levels and the metabolic syndrome among Korean people.
Kim SM; Cho KH; Park HS
Endocr J; 2006 Apr; 53(2):247-54. PubMed ID: 16618984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
